<b>Gapping up<br/></b><u>In reaction to strong earnings/guidance: </u> TIF +4.7%, QTWW +1.1%, SAP +1.1%, ITW +0.9% (light volume).<br/><br/><u>M&A news:</u> VRGY +12.2% (Verigy Board of Directors determines that Advantest proposal is superior to LTX-Credence merger).<br/><br/><u>Select financial related names showing strength</u>: HIG +4.4%, C +3.6% (announces 1-10 reverse stock split and intends to reinstate a quarterly dividend of $0.01 per common share in Q2), BCS +3.1%, STD +2.9%, DB +2.4%, LYG +2.1%, HBC +2%, UBS +1.6%, BAC +1.3%, GS +1.2%.<br/><br/><u>Select metals/mining stocks trading higher:</u> SWC +4.5%, SLW +4.2%, MT +2.9%, RIO +2.6%, AUY +2.1%, BBL +1.9%, BHP +1.6%, GLD +0.7%.<br/><br/><u>A few uranium names trading higher: </u> URRE +9.7%, DNN +9.2%, CCJ +7.1%, URG +6.5%.<br/><br/><u>Select oil/gas related names showing strength: </u> ROYL +9.3%, ATPG +3.8%, WFT +2.7%, RIG +2.2%, BP +0.9%, RDS.A +0.6%.<br/><br/><u>A few telecom and commuication related stocks are lifting in premarket:</u> PCS +5.8%, VOD +4.4%, LEAP +4.6%, NVTL +4.5%, T +4.1% (AT&T to acquire T-Mobile USA from Deutsche Telekom in deal valued at ~$39 bln; expected to be earnings accretive in the third year; upgraded to Buy at Citigroup), CHU +3.8%, ALU +3.4%, VZ +2.1%,<br/><br/><u>Other news</u>: CRIS +14.3% (reports positive results in Genentech Pivotal Phase II Clinical Trial of GDC-0449 in Advanced Basal Cell Carcinoma), DXCM +7.4%, TRNX +6.1%, PODD +5.1% and HTWR +3.5% (all higher following Cramer positive comments on MadMoney), JDSU +3.2% (still checking), SI +2.7% (still checking), GE +2.3% (still checking), HPQ +1.6% (hearing reports out that complaints related to board selection have been rejected), ARMH +1.6% (still checking), KEY +1.5% (prices 70,621,470 shares of common stock at $8.85 per share), SVU +1.2% (strength attributed to positive mention in financial newspaper), GM +1.1% (reports out the co is planning spending cuts), STI +1.1% (priced a ~35.25 mln share common stock offering at $29.50/share).<br/><br/><u>Analyst comments: </u> EMC +2.8% (upgraded to Conviction Buy from Buy at Goldman), POT +2.6% (upgraded to Buy from Neutral at Goldman), QCOM +1% (upgraded to Buy at Sterne Agee).